RxDoctor Payments Data

Samir Sheth, MD

Pain Medicine · Roseville, CANPI 1720245830

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (41.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medtronic at 36.9% of the total. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$356,274in general payments, 2019–2025

Across 1,011 payments — averaging $352.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$131K
  • SPR Therapeutics, Inc$127K
  • Boston Scientific$53K
  • Vertos Medical, Inc.$10K
  • Si-bone, Inc.$7K
  • Nevro Corp.$6K
  • plus $22K from 18 others
$30,787in research payments, 2019–2025

Across 6 payments — averaging $5131.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$16K
  • Boston Scientific$15K
  • Saluda Medical Americas, Inc.$62

What the payments were for

  • Consulting fees$126,25835%
  • Speaking & faculty fees$149,31242%
  • Travel & lodging$49,06514%
  • Food & beverage$31,5699%
  • Education$700%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$356,274 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California

Medicare billing

Part B allowed, 2024
$418,739
Medicare patients
713
Services billed
11,379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl19$18,574
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen125$2,338
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen43$2,286
Fentanyl11$828
Gabapentin52$604
Morphine Sulfate12$334
Pregabalin22$201
Celecoxib13$184
Tramadol Hcl18$175
Methylprednisolone17$160
Meloxicam42$104

Paid to pharmacies, not to this prescriber.

Other pain medicine in Roseville

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →